Richard W. Paul & Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-26
Closed -$2.36K 372
2024
Q4
$2.36K Hold
26
﹤0.01% 405
2024
Q3
$2.7K Hold
26
﹤0.01% 394
2024
Q2
$2.52K Hold
26
﹤0.01% 398
2024
Q1
$2.34K Hold
26
﹤0.01% 421
2023
Q4
$2.07K Hold
26
﹤0.01% 412
2023
Q3
$1.85K Sell
26
-14
-35% -$1.05K ﹤0.01% 409
2023
Q2
$3.08K Hold
40
﹤0.01% 400
2023
Q1
$3.01K Sell
40
-1
-2% -$74 ﹤0.01% 413
2022
Q4
$3.23K Buy
+41
New +$3.07K ﹤0.01% 403

Other funds holding CL

Richard W. Paul & Associates's CL Position: Q1 2025 in Review

Richard W. Paul & Associates sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 26 shares — an estimated $2.36K sold.

Richard W. Paul & Associates first reported a position in CL in Q4 2022 and held it in 9 quarters. The position peaked at $3.23K in Q4 2022. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • Richard W. Paul & Associates reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
  • Richard W. Paul & Associates sold 26 Colgate-Palmolive shares in Q1 2025, an estimated $2.36K.
  • Richard W. Paul & Associates first reported a position in Colgate-Palmolive in Q4 2022 and held it in 9 quarters.
  • Richard W. Paul & Associates's Colgate-Palmolive position peaked at $3.23K in Q4 2022.
  • 1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Richard W. Paul & Associates's 13F filing for Q1 2025, filed 12 May 2025.